chr7-134447336-T-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM1PM2
The NM_001628.4(AKR1B1):āc.787A>Gā(p.Lys263Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000979 in 1,613,976 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00011 ( 0 hom., cov: 32)
Exomes š: 0.000096 ( 0 hom. )
Consequence
AKR1B1
NM_001628.4 missense
NM_001628.4 missense
Scores
5
10
4
Clinical Significance
Conservation
PhyloP100: 7.99
Genes affected
AKR1B1 (HGNC:381): (aldo-keto reductase family 1 member B) This gene encodes a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and proteins. This member catalyzes the reduction of a number of aldehydes, including the aldehyde form of glucose, and is thereby implicated in the development of diabetic complications by catalyzing the reduction of glucose to sorbitol. Multiple pseudogenes have been identified for this gene. The nomenclature system used by the HUGO Gene Nomenclature Committee to define human aldo-keto reductase family members is known to differ from that used by the Mouse Genome Informatics database. [provided by RefSeq, Feb 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM1
In a modified_residue N6-acetyllysine (size 0) in uniprot entity ALDR_HUMAN
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AKR1B1 | NM_001628.4 | c.787A>G | p.Lys263Glu | missense_variant | 8/10 | ENST00000285930.9 | |
AKR1B1 | NM_001346142.1 | c.355A>G | p.Lys119Glu | missense_variant | 8/10 | ||
AKR1B1 | NR_144376.2 | n.1423A>G | non_coding_transcript_exon_variant | 7/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AKR1B1 | ENST00000285930.9 | c.787A>G | p.Lys263Glu | missense_variant | 8/10 | 1 | NM_001628.4 | P1 | |
AKR1B1 | ENST00000465351.5 | n.1425A>G | non_coding_transcript_exon_variant | 7/9 | 1 | ||||
AKR1B1 | ENST00000467251.1 | n.91A>G | non_coding_transcript_exon_variant | 2/3 | 4 | ||||
AKR1B1 | ENST00000434222.5 | c.*514A>G | 3_prime_UTR_variant, NMD_transcript_variant | 8/10 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152138Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
17
AN:
152138
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000183 AC: 46AN: 251428Hom.: 0 AF XY: 0.000213 AC XY: 29AN XY: 135892
GnomAD3 exomes
AF:
AC:
46
AN:
251428
Hom.:
AF XY:
AC XY:
29
AN XY:
135892
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000965 AC: 141AN: 1461838Hom.: 0 Cov.: 32 AF XY: 0.000110 AC XY: 80AN XY: 727216
GnomAD4 exome
AF:
AC:
141
AN:
1461838
Hom.:
Cov.:
32
AF XY:
AC XY:
80
AN XY:
727216
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000112 AC: 17AN: 152138Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74312
GnomAD4 genome
AF:
AC:
17
AN:
152138
Hom.:
Cov.:
32
AF XY:
AC XY:
11
AN XY:
74312
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
5
ExAC
AF:
AC:
24
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 17, 2021 | The c.787A>G (p.K263E) alteration is located in exon 8 (coding exon 8) of the AKR1B1 gene. This alteration results from a A to G substitution at nucleotide position 787, causing the lysine (K) at amino acid position 263 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
M_CAP
Benign
D
MetaRNN
Uncertain
D
MetaSVM
Benign
T
MutationAssessor
Pathogenic
H
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D
REVEL
Uncertain
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
P
Vest4
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at